Literature DB >> 20936528

Iron intake and markers of iron status and risk of Barrett's esophagus and esophageal adenocarcinoma.

Mark G O'Doherty1, Christian C Abnet, Liam J Murray, Jayne V Woodside, Lesley A Anderson, John D Brockman, Marie M Cantwell.   

Abstract

OBJECTIVE: To investigate the association between iron intake and iron status with Barrett's esophagus (BE) and esophageal adenocarcinoma (EAC).
METHODS: A total of 220 BE patients, 224 EAC patients, and 256 frequency-matched controls completed a lifestyle and food frequency questionnaire and provided serum and toenail samples between 2002 and 2005. Using multiple logistic regression, odds ratios (OR) and 95% confidence intervals (95% CI) were calculated within quartiles of intake/status.
RESULTS: Comparing the fourth to the first quartile, ferritin (OR 0.47; 95% CI: 0.23, 0.97) and transferrin saturation (OR 0.41; 95% CI: 0.20, 0.82) were negatively associated with BE; while total iron binding capacity was positively associated per 50 μg/dl increment (OR 1.47; 95% CI: 1.12, 1.92). Comparing the fourth to the first quartile, iron intake (OR 0.50; 95% CI: 0.25, 0.98), non-heme iron intake per 10 mg/day increment (OR 0.29; 95% CI: 0.08, 0.99), and toenail iron (OR 0.40; 95% CI: 0.17, 0.93) were negatively associated with EAC; while heme iron intake was positively associated (OR 3.11 95% CI: 1.46, 6.61). PRINCIPAL
CONCLUSION: In contrast to the hypothesis that increased iron intakes and higher iron stores are a risk factor for BE and EAC, this study suggests that higher iron intakes and stores may have a protective association with BE and EAC, with the exception of what was found for heme iron intake.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20936528      PMCID: PMC3438890          DOI: 10.1007/s10552-010-9652-0

Source DB:  PubMed          Journal:  Cancer Causes Control        ISSN: 0957-5243            Impact factor:   2.506


  65 in total

Review 1.  Epidemiologic trends in esophageal and gastric cancer in the United States.

Authors:  Linda Morris Brown; Susan S Devesa
Journal:  Surg Oncol Clin N Am       Date:  2002-04       Impact factor: 3.495

2.  Risk of primary non-hepatocellular malignancies in hereditary hemochromatosis.

Authors:  Debra Geier; Brian Hebert; Anil Potti
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

3.  Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.

Authors:  Thomas A Pearson; George A Mensah; R Wayne Alexander; Jeffrey L Anderson; Richard O Cannon; Michael Criqui; Yazid Y Fadl; Stephen P Fortmann; Yuling Hong; Gary L Myers; Nader Rifai; Sidney C Smith; Kathryn Taubert; Russell P Tracy; Frank Vinicor
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

4.  Nutrient intakes and adenocarcinoma of the esophagus and distal stomach.

Authors:  Honglei Chen; Katherine L Tucker; Barry I Graubard; Ellen F Heineman; Rodney S Markin; Nancy A Potischman; Robert M Russell; Dennis D Weisenburger; Mary H Ward
Journal:  Nutr Cancer       Date:  2002       Impact factor: 2.900

5.  The North/South Ireland Food Consumption Survey: mineral intakes in 18-64-year-old adults.

Authors:  E M Hannon; M Kiely; K E Harrington; P J Robson; J J Strain; A Flynn
Journal:  Public Health Nutr       Date:  2001-10       Impact factor: 4.022

6.  Dietary factors associated with the risk of high iron stores in the elderly Framingham Heart Study cohort.

Authors:  Diana J Fleming; Katherine L Tucker; Paul F Jacques; Gerard E Dallal; Peter W F Wilson; Richard J Wood
Journal:  Am J Clin Nutr       Date:  2002-12       Impact factor: 7.045

7.  Relationship of body iron stores to levels of serum ferritin, serum iron, unsaturated iron binding capacity and transferrin saturation in patients with iron storage disease.

Authors:  Ernest Beutler; Vincent Felitti; Ngoc J Ho; Terri Gelbart
Journal:  Acta Haematol       Date:  2002       Impact factor: 2.195

Review 8.  The epidemic of esophageal adenocarcinoma.

Authors:  Hashem B el-Serag
Journal:  Gastroenterol Clin North Am       Date:  2002-06       Impact factor: 3.806

9.  Dietary exposure and urinary excretion of total N-nitroso compounds, nitrosamino acids and volatile nitrosamine in inhabitants of high- and low-risk areas for esophageal cancer in southern China.

Authors:  Kun Lin; Wenying Shen; Zhongying Shen; Yongning Wu; Shihhsin Lu
Journal:  Int J Cancer       Date:  2002-11-20       Impact factor: 7.396

10.  A cohort study of dietary iron and heme iron intake and risk of colorectal cancer in women.

Authors:  G C Kabat; A B Miller; M Jain; T E Rohan
Journal:  Br J Cancer       Date:  2007-06-05       Impact factor: 7.640

View more
  7 in total

1.  Heme iron from meat and risk of adenocarcinoma of the esophagus and stomach.

Authors:  Mary H Ward; Amanda J Cross; Christian C Abnet; Rashmi Sinha; Rodney S Markin; Dennis D Weisenburger
Journal:  Eur J Cancer Prev       Date:  2012-03       Impact factor: 2.497

2.  Toenail trace element status and risk of Barrett's oesophagus and oesophageal adenocarcinoma: results from the FINBAR study.

Authors:  Michael A O'Rorke; Marie M Cantwell; Christian C Abnet; And John D Brockman; Liam J Murray
Journal:  Int J Cancer       Date:  2012-03-06       Impact factor: 7.396

Review 3.  Review: Experimental models for Barrett's esophagus and esophageal adenocarcinoma.

Authors:  Katherine S Garman; Roy C Orlando; Xiaoxin Chen
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2012-03-15       Impact factor: 4.052

4.  Micronutrients: A double-edged sword in microbial-induced gastric carcinogenesis.

Authors:  Jennifer M Noto; Richard M Peek
Journal:  Trends Cancer       Date:  2015-10-01

5.  Toenail iron, genetic determinants of iron status, and the risk of glioma.

Authors:  Gabriella M Anic; Melissa H Madden; Reid C Thompson; L Burton Nabors; Jeffrey J Olson; Renato V Larocca; James E Browning; John D Brockman; Peter A Forsyth; Kathleen M Egan
Journal:  Cancer Causes Control       Date:  2013-08-31       Impact factor: 2.506

6.  Dietary Risk Reduction Factors for the Barrett's Esophagus-Esophageal Adenocarcinoma Continuum: A Review of the Recent Literature.

Authors:  Jessica L Petrick; Nan Li; Kathleen M McClain; Susan E Steck; Marilie D Gammon
Journal:  Curr Nutr Rep       Date:  2015-03-01

7.  Association between circulating levels of sex steroid hormones and esophageal adenocarcinoma in the FINBAR Study.

Authors:  Jessica L Petrick; Roni T Falk; Paula L Hyland; Patrick Caron; Ruth M Pfeiffer; Shannon N Wood; Sanford M Dawsey; Christian C Abnet; Philip R Taylor; Chantal Guillemette; Liam J Murray; Lesley A Anderson; Michael B Cook
Journal:  PLoS One       Date:  2018-01-17       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.